Results 151 to 160 of about 126,591 (208)

Talc slurry pleurodesis in patients with secondary intractable pneumothorax: A phase 2 study.

open access: yesRespiratory Investigation
Secondary pneumothorax, which occurs most commonly in the elderly, is caused by underlying diseases. Cardiac dysfunction and other organ inefficiencies may render surgical repair impossible. Such non-operative and poor-risk cases are targets for pleurodesis, which involves the instillation of chemicals or irritants to the thoracic cavity through ...
H. Saka   +11 more
semanticscholar   +4 more sources

Outcomes of the management of malignant pleural effusions with talc poudrage or talc slurry following medical thoracoscopy

11.2 Pleural and Mediastinal Malignancies, 2015
Background: Aintree Chest Centre has an established medical thoracoscopy (MT) service. Over recent years some cases have been managed with talc poudrage (TP) and others with talc slurry (TS) via the chest drain once histology is available. We were interested in the efficacy of talc poudrage compared to talc slurry following MT and also talc slurry via
Ben H Vlies   +5 more
semanticscholar   +2 more sources

Success rates of talc slurry pleurodesis - A 2 years review

1.13 Clinical Problems - Other, 2015
Background: Approximately 50% of patients with metastatic malignancy develop a pleural effusion. Talc pleurodesis (TP) is currently first line treatment; trials have shown Tunnelled Indwelling Pleural Catheters (TIPC) have similar symptomatic benefit. We noticed that on this pleural unit in a large teaching hospital pleural effusions due to breast and
Joy M. Thomas, J. Bonsall, A. Ionescu
semanticscholar   +2 more sources

Pleurodesis success rate for malignant pleural effusions - talc slurry vs. poudrage

11.2 Pleural and Mediastinal Malignancies, 2016
Introduction: Talc pleurodesis remains the mainstay of treatment for malignant pleural effusions (MPE). We sought to establish the efficacy of talc slurry (TS) and poudrage (TP) and whether this differs by tumour type. Method: A retrospective cohort analysis of MPE patients undergoing 4g Steritalc thoracoscopic TP (Jan 2006-Dec 2013) and TS (Jan 2012 ...
K. Boksh   +5 more
semanticscholar   +2 more sources

Successful talc slurry pleurodesis in patients with nonmalignant pleural effusion.

Chest, 2000
Chemical pleurodesis is an effective treatment for malignant pleural effusion and pneumothorax. This mode of therapy is, however, less widely accepted in the treatment of patients with refractory benign or undiagnosed pleural effusion.To analyze the outcome of talc slurry pleurodesis in patients with nonmalignant pleural effusions.Retrospective and ...
M. Glazer   +3 more
semanticscholar   +3 more sources

Serious complications with talc slurry pleurodesis

Respirology, 2001
Talc is a highly efficacious and commonly employed agent for chemical pleurodesis, which has generally been felt to be well tolerated. However, increasing reports of adult respiratory distress syndrome (ARDS) have heightened safety concerns. A recent case of ARDS prompted us to review our experience with talc pleurodesis.We conducted a retrospective ...
A, Brant, T, Eaton
openaire   +2 more sources

Talc pleurodesis: Talc slurry versus thoracoscopic talc insufflation in a porcine model

The Annals of Thoracic Surgery, 1996
Pleurodesis using both talc slurry and thoracoscopic talc insufflation has been shown to be clinically effective. This study compares these two modalities of pleural talc instillation in an animal model.Eleven immature pigs underwent general endotracheal anesthesia. On one side, a slurry of 5 g sterile United States Pharmacopeia talc in 50 mL of saline
R G, Cohen   +6 more
openaire   +2 more sources

Thoracoscopic Talc Insufflation Versus Talc Slurry for Symptomatic Malignant Pleural Effusion

The Annals of Thoracic Surgery, 1996
Talc has been generally accepted to be the most effective sclerosant for chemical pleurodesis, although the optimal route of administration remains unclear.We designed a prospective, randomized study to compare video-assisted thoracoscopic talc insufflation with bedside talc slurry in the treatment of malignant pleural effusion.
A P, Yim   +4 more
openaire   +2 more sources

Severe interstitial pneumonia associated with anti-PD-1 immune checkpoint antibody after talc slurry pleurodesis.

Respiratory Investigation, 2017
A 70-year-old Japanese man with recurrent squamous cell carcinoma of the head and neck presented with severe interstitial pneumonia associated with nivolumab, after talc slurry pleurodesis. Following the development of malignant pleural effusion, he underwent chest drainage and was administered intrathoracic talc as a pleurodesis.
S. Sakata   +9 more
semanticscholar   +3 more sources

Home - About - Disclaimer - Privacy